Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Income from Continuous Operations 2010-2025 | MKKGY

Merck annual/quarterly income from continuous operations history and growth rate from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • Merck income from continuous operations for the quarter ending March 31, 2025 was $0.777B, a 2.45% increase year-over-year.
  • Merck income from continuous operations for the twelve months ending March 31, 2025 was $3.033B, a 2.22% increase year-over-year.
  • Merck annual income from continuous operations for 2024 was $3.015B, a 1.71% decline from 2023.
  • Merck annual income from continuous operations for 2023 was $3.067B, a 12.81% decline from 2022.
  • Merck annual income from continuous operations for 2022 was $3.518B, a 2.98% decline from 2021.
  
Merck Annual Income from Continuous Operations
(Millions of US $)
2024 $3,015
2023 $3,067
2022 $3,518
2021 $3,626
2020 $2,278
2019 $1,452
2018 $1,291
2017 $2,950
2016 $1,807
2015 $1,241
2014 $2,240
2013 $2,535
2012 $2,125
2011 $1,948
2010 $839
2009 $536
Merck Quarterly Income from Continuous Operations
(Millions of US $)
2025-03-31 $777
2024-12-31 $711
2024-09-30 $893
2024-06-30 $652
2024-03-31 $759
2023-12-31 $633
2023-09-30 $805
2023-06-30 $770
2023-03-31 $859
2022-12-31 $667
2022-09-30 $933
2022-06-30 $926
2022-03-31 $992
2021-12-31 $923
2021-09-30 $901
2021-06-30 $900
2021-03-31 $902
2020-12-31 $512
2020-09-30 $942
2020-06-30 $318
2020-03-31 $505
2019-12-31 $375
2019-09-30 $377
2019-06-30 $473
2019-03-31 $226
2018-12-31 $204
2018-09-30 $376
2018-06-30 $291
2018-03-31 $420
2017-12-31 $1,165
2017-09-30 $763
2017-06-30 $465
2017-03-31 $557
2016-12-31 $285
2016-09-30 $513
2016-06-30 $355
2016-03-31 $654
2015-12-31 $138
2015-09-30 $407
2015-06-30 $380
2015-03-31 $321
2014-12-31 $313
2014-09-30 $331
2014-06-30 $405
2014-03-31 $446
2013-12-31 $382
2013-09-30 $450
2013-06-30 $419
2013-03-31 $345
2012-12-31 $350
2012-09-30 $232
2012-06-30 $-78
2012-03-31 $222
2011-12-31 $178
2011-09-30 $321
2011-06-30 $-124
2011-03-31 $466
2010-12-31 $89
2010-09-30 $272
2010-06-30 $224
2010-03-31 $255
2009-12-31 $107
2009-09-30 $206
2009-06-30 $148
2009-03-31 $75
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.273B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $77.043B 28.90
Zoetis (ZTS) United States $70.699B 26.38
Takeda Pharmaceutical (TAK) Japan $47.220B 9.39
Daiichi Sankyo, - (DSNKY) Japan $41.486B 21.26
BeOne Medicines - (ONC) Cayman Islands $27.772B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.640B 0.00
Summit Therapeutics (SMMT) United States $19.220B 0.00
Shionogi (SGIOY) Japan $14.343B 14.37
United Therapeutics (UTHR) United States $13.539B 11.98
Neurocrine Biosciences (NBIX) United States $13.352B 45.74
Orion OYJ (ORINY) Finland $11.119B 30.07
IPSEN (IPSEY) France $10.299B 0.00
Stevanato Group S.p.A (STVN) Italy $7.856B 48.04
Corcept Therapeutics (CORT) United States $7.636B 62.08
Madrigal Pharmaceuticals (MDGL) United States $6.986B 0.00
Ionis Pharmaceuticals (IONS) United States $6.745B 0.00
Grifols, S.A (GRFS) Spain $6.704B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.068B 15.41
Soleno Therapeutics (SLNO) United States $4.048B 0.00
Hypermarcas (HYPMY) Brazil $3.182B 20.93
Crinetics Pharmaceuticals (CRNX) United States $2.995B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.665B 9.34
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.630B 14.22
NewAmsterdam Pharma (NAMS) Netherlands $2.472B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.957B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.858B 0.00
ARS Pharmaceuticals (SPRY) United States $1.766B 0.00
Ocular Therapeutix (OCUL) United States $1.765B 0.00
Endo (NDOI) United States $1.602B 0.00
ProKidney (PROK) United States $1.516B 0.00
Evotec AG (EVO) Germany $1.481B 0.00
Guardian Pharmacy Services (GRDN) United States $1.319B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.206B 24.14
Harrow (HROW) United States $1.151B 0.00
Ardelyx (ARDX) United States $1.125B 0.00
Enliven Therapeutics (ELVN) United States $1.118B 0.00
Collegium Pharmaceutical (COLL) United States $1.060B 5.72
Akebia Therapeutics (AKBA) United States $1.045B 0.00
Dyne Therapeutics (DYN) United States $1.000B 0.00
Verve Therapeutics (VERV) United States $0.986B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.945B 0.00
Xeris Biopharma Holdings (XERS) United States $0.824B 0.00
Cronos Group (CRON) Canada $0.810B 0.00
KalVista Pharmaceuticals (KALV) United States $0.771B 0.00
Xencor (XNCR) United States $0.660B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.659B 0.00
Zevra Therapeutics (ZVRA) United States $0.657B 0.00
Relay Therapeutics (RLAY) United States $0.639B 0.00
USANA Health Sciences (USNA) United States $0.622B 13.53
Bioventus (BVS) United States $0.607B 15.40
Theravance Biopharma (TBPH) United States $0.573B 0.00
Organogenesis (ORGO) United States $0.558B 0.00
Elite Pharmaceuticals (ELTP) United States $0.556B 0.00
Oruka Therapeutics (ORKA) United States $0.527B 0.00
Siga Technologies (SIGA) United States $0.493B 10.30
Tourmaline Bio (TRML) United States $0.446B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Savara (SVRA) United States $0.398B 0.00
Altimmune (ALT) United States $0.357B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.350B 9.47
Heron Therapeutics (HRTX) United States $0.339B 0.00
AleAnna (ANNA) United States $0.315B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.312B 0.00
Nektar Therapeutics (NKTR) United States $0.311B 0.00
Nature's Sunshine Products (NATR) United States $0.289B 26.52
Aldeyra Therapeutics (ALDX) United States $0.288B 0.00
OmniAb (OABI) United States $0.252B 0.00
Nanobiotix S.A (NBTX) France $0.247B 0.00
Esperion Therapeutics (ESPR) United States $0.246B 0.00
MediWound (MDWD) Israel $0.228B 0.00
Larimar Therapeutics (LRMR) United States $0.223B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
China SXT Pharmaceuticals (SXTC) China $0.198B 0.00
Liminatus Pharma (LIMN) United States $0.187B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.172B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Avita Medical (RCEL) United States $0.157B 0.00
Galectin Therapeutics (GALT) United States $0.155B 0.00
Lexeo Therapeutics (LXEO) United States $0.152B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Lyell Immunopharma (LYEL) United States $0.145B 0.00
Korro Bio (KRRO) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.126B 0.00
Champions Oncology (CSBR) United States $0.122B 20.02
Protara Therapeutics (TARA) United States $0.120B 0.00
Cardiol Therapeutics (CRDL) Canada $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Nutriband (NTRB) United States $0.091B 0.00
Metagenomi (MGX) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Achieve Life Sciences (ACHV) Canada $0.081B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.081B 0.00
VAXART, INC (VXRT) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Klotho Neurosciences (KLTO) United States $0.077B 0.00
Rafael Holdings (RFL) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Fractyl Health (GUTS) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Wellgistics Health (WGRX) United States $0.072B 0.00
Dominari Holdings (DOMH) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
PMV Pharmaceuticals (PMVP) United States $0.066B 0.00
Jupiter Neurosciences (JUNS) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Century Therapeutics (IPSC) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 37.11
Iterum Therapeutics (ITRM) Ireland $0.043B 0.00
Karyopharm Therapeutics (KPTI) United States $0.043B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Vivos Therapeutics (VVOS) United States $0.039B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.030B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.022B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 2.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.99
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00